TY - JOUR AU - Martin, K. AU - Bégaud, B. AU - Latry, P. AU - Miremont-Salamé, G. AU - Fourrier, A. AU - Moore, N. PY - 2004 DA - 2004// TI - Differences between clinical trials and postmarketing use JO - Br J Clin Pharmacol VL - 57 UR - https://doi.org/10.1046/j.1365-2125.2003.01953.x DO - 10.1046/j.1365-2125.2003.01953.x ID - Martin2004 ER - TY - JOUR AU - Lassila, R. AU - Rothschild, C. AU - De Moerloose, P. AU - Richards, M. AU - Perez, R. AU - Gajek, H. PY - 2005 DA - 2005// TI - European Haemophilia Therapy Standardisation Board. Recommendations for postmarketing surveillance studies in haemophilia and other bleeding disorders JO - Haemophilia VL - 11 UR - https://doi.org/10.1111/j.1365-2516.2005.01114.x DO - 10.1111/j.1365-2516.2005.01114.x ID - Lassila2005 ER - TY - JOUR AU - Hazell, L. AU - Shakir, S. A. W. PY - 2006 DA - 2006// TI - Under-reporting of adverse drug reactions: a systematic review JO - Drug Saf VL - 29 UR - https://doi.org/10.2165/00002018-200629050-00003 DO - 10.2165/00002018-200629050-00003 ID - Hazell2006 ER - TY - JOUR AU - Basch, E. PY - 2010 DA - 2010// TI - The missing voice of patients in drug-safety reporting JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMp0911494 DO - 10.1056/NEJMp0911494 ID - Basch2010 ER - TY - JOUR AU - Weingart, S. N. AU - Gandhi, T. K. AU - Seger, A. C. AU - Seger, D. L. AU - Borus, J. AU - Burdick, E. AU - Leape, L. L. AU - Bates, D. W. PY - 2005 DA - 2005// TI - Patient-reported medication symptoms in primary care JO - Arch Intern Med VL - 165 UR - https://doi.org/10.1001/archinte.165.2.234 DO - 10.1001/archinte.165.2.234 ID - Weingart2005 ER - TY - JOUR AU - Ligthelm, R. J. AU - Borzì, V. AU - Gumprecht, J. AU - Kawamori, R. AU - Wenying, Y. AU - Valensi, P. PY - 2007 DA - 2007// TI - Importance of observational studies in clinical practice JO - Clin Ther VL - 29 UR - https://doi.org/10.1016/j.clinthera.2007.07.004 DO - 10.1016/j.clinthera.2007.07.004 ID - Ligthelm2007 ER - TY - JOUR AU - Mann, R. D. PY - 1998 DA - 1998// TI - Prescription-event monitoring--recent progress and future horizons JO - Br J Clin Pharmacol VL - 46 UR - https://doi.org/10.1046/j.1365-2125.1998.00774.x DO - 10.1046/j.1365-2125.1998.00774.x ID - Mann1998 ER - TY - JOUR AU - Bent, S. AU - Padula, A. AU - Avins, A. L. PY - 2006 DA - 2006// TI - Brief communication: Better ways to question patients about adverse medical events: A Randomized, Controlled Trial JO - Ann Intern Med VL - 144 UR - https://doi.org/10.7326/0003-4819-144-4-200602210-00007 DO - 10.7326/0003-4819-144-4-200602210-00007 ID - Bent2006 ER - TY - JOUR AU - Field, T. S. AU - Gurwitz, J. H. AU - Harrold, L. R. AU - Rothschild, J. M. AU - DeBellis, K. AU - Seger, A. C. AU - Fish, L. S. AU - Garber, L. AU - Kelleher, M. AU - Bates, D. W. PY - 2004 DA - 2004// TI - Strategies for detecting adverse drug events among older persons in the ambulatory setting JO - J Am Med Inform Assoc VL - 11 UR - https://doi.org/10.1197/jamia.M1586 DO - 10.1197/jamia.M1586 ID - Field2004 ER - TY - CHAP PY - 2011 DA - 2011// BT - ICH Topic E 2 E Pharmacovigilance Planning (Pvp) Note for guidance on planning pharmacovigilance activities (CPMP/ICH/5716/03) [online] ID - ref10 ER - TY - CHAP PY - 2011 DA - 2011// BT - ICH Topic E1 The Extent of Population Exposure to Assess Clinical Safety for Drugs Intended for Long-Term Treatment of Non-Life-Threatening Conditions (CPMP/ICH/375/95) [online] ID - ref11 ER - TY - CHAP PY - 2011 DA - 2011// BT - Guidance for Industry. Premarketing Risk Assessment, March 2005 [online] ID - ref12 ER - TY - CHAP PY - 2011 DA - 2011// BT - ICH Topic E6 (R1) Guideline for Good Clinical Practice (CPMP/ICH/135/95) [online] ID - ref13 ER - TY - JOUR AU - Morimoto, T. AU - Gandhi, T. K. AU - Seger, A. C. AU - Hsieh, T. C. AU - Bates, D. W. PY - 2004 DA - 2004// TI - Adverse drug events and medication errors: detection and classification methods JO - Qual Saf Health Care VL - 13 UR - https://doi.org/10.1136/qshc.2004.010611 DO - 10.1136/qshc.2004.010611 ID - Morimoto2004 ER - TY - CHAP PY - 2011 DA - 2011// BT - Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0, August 9, 2006 [online] ID - ref15 ER - TY - CHAP PY - 2011 DA - 2011// BT - Guidance for Industry. Diabetes Mellitus - Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes December, 2008 [online] ID - ref16 ER - TY - CHAP PY - 2011 DA - 2011// BT - Guideline on clinical investigation of medicinal products in the treatment of diabetes mellitus. Draft. CPMP/EWP/1080/00 Rev. 1. 20 Jan 2010 [online] ID - ref17 ER - TY - JOUR AU - Bytzer, P. AU - Talley, N. J. AU - Jones, M. P. AU - Horowitz, M. PY - 2001 DA - 2001// TI - Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus JO - Aliment Pharmacol Ther VL - 15 UR - https://doi.org/10.1046/j.1365-2036.2001.00896.x DO - 10.1046/j.1365-2036.2001.00896.x ID - Bytzer2001 ER - TY - JOUR AU - Woodcock, A. AU - Bain, S. AU - Charlton, M. AU - Bradley, C. PY - 2007 DA - 2007// TI - Extent of satisfaction with tablets and food-timing in sulphonylurea-treated diabetes JO - Diabetes Res Clin Pract VL - 78 UR - https://doi.org/10.1016/j.diabres.2005.07.013 DO - 10.1016/j.diabres.2005.07.013 ID - Woodcock2007 ER - TY - JOUR AU - Vexiau, P. AU - Mavros, P. AU - Krishnarajah, G. AU - Lyu, R. AU - Yin, D. PY - 2008 DA - 2008// TI - Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France JO - Diabetes Obes Metab VL - 10 UR - https://doi.org/10.1111/j.1463-1326.2008.00883.x DO - 10.1111/j.1463-1326.2008.00883.x ID - Vexiau2008 ER - TY - JOUR AU - Haugbolle, L. S. AU - Sorensen, E. W. PY - 2006 DA - 2006// TI - Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma - interviewing patients at home JO - Pharm World Sci VL - 28 UR - https://doi.org/10.1007/s11096-006-9023-9 DO - 10.1007/s11096-006-9023-9 ID - Haugbolle2006 ER - TY - JOUR AU - Yusuff, K. B. AU - Obe, O. AU - Joseph, B. Y. PY - 2008 DA - 2008// TI - Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria JO - Pharm World Sci VL - 30 UR - https://doi.org/10.1007/s11096-008-9243-2 DO - 10.1007/s11096-008-9243-2 ID - Yusuff2008 ER - TY - JOUR AU - Klocke, K. R. AU - Stauch, K. AU - Landen, H. PY - 2003 DA - 2003// TI - Effect of add-on acarbose to insulin therapy in routine clinical practice JO - Clin Drug Invest VL - 23 UR - https://doi.org/10.2165/00044011-200323100-00001 DO - 10.2165/00044011-200323100-00001 ID - Klocke2003 ER - TY - JOUR AU - Guagnano, M. T. AU - Pace-Palitti, V. AU - Formisano, S. AU - Della Loggia, F. AU - D'Anchino, M. AU - Della Vecchia, R. AU - Merlitti, D. AU - Sensi, S. PY - 2000 DA - 2000// TI - Does holiday hypoglycaemia exist? JO - Panminerva Med VL - 42 ID - Guagnano2000 ER - TY - JOUR AU - Jick, S. S. AU - Stender, M. AU - Myers, M. W. PY - 1999 DA - 1999// TI - Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents JO - Diabetes Care VL - 22 UR - https://doi.org/10.2337/diacare.22.12.2067 DO - 10.2337/diacare.22.12.2067 ID - Jick1999 ER - TY - JOUR PY - 2007 DA - 2007// TI - Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration JO - Diabetologia VL - 50 UR - https://doi.org/10.1007/s00125-007-0599-y DO - 10.1007/s00125-007-0599-y ID - ref26 ER - TY - JOUR AU - Taki, H. AU - Maki, T. AU - Iso, T. AU - Tanabe, S. AU - Kajiura, T. PY - 2005 DA - 2005// TI - Postmarketing study of nateglinide in Japan: treatment of medication-naive patients with type 2 diabetes JO - Adv Ther VL - 22 UR - https://doi.org/10.1007/BF02849956 DO - 10.1007/BF02849956 ID - Taki2005 ER - TY - JOUR AU - Taki, H. AU - Maki, T. AU - Iso, T. AU - Iwamoto, K. AU - Kajiura, T. PY - 2005 DA - 2005// TI - Postmarketing surveillance study of nateglinide in Japan JO - Adv Ther VL - 22 UR - https://doi.org/10.1007/BF02849871 DO - 10.1007/BF02849871 ID - Taki2005 ER - TY - JOUR AU - Biswas, P. AU - Wilton, L. V. AU - Shakir, S. A. W. PY - 2001 DA - 2001// TI - Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reporting JO - Drug Saf VL - 24 UR - https://doi.org/10.2165/00002018-200124020-00004 DO - 10.2165/00002018-200124020-00004 ID - Biswas2001 ER - TY - JOUR AU - Landgraf, R. AU - Frank, M. AU - Bauer, C. AU - Dieken, M. L. PY - 2000 DA - 2000// TI - Prandial glucose regulation with repaglinide: its clinical and lifestyle impact in a large cohort of patients with Type 2 diabetes JO - Int J Obes Relat Metab Disord VL - 24 UR - https://doi.org/10.1038/sj.ijo.0801424 DO - 10.1038/sj.ijo.0801424 ID - Landgraf2000 ER - TY - JOUR AU - Chao, J. AU - Nau, D. P. AU - Aikens, J. E. PY - 2007 DA - 2007// TI - Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus JO - Clin Ther VL - 29 UR - https://doi.org/10.1016/j.clinthera.2007.01.014 DO - 10.1016/j.clinthera.2007.01.014 ID - Chao2007 ER - TY - JOUR AU - Karagiannis, E. AU - Pfutzner, A. AU - Forst, T. AU - Lubben, G. AU - Roth, W. AU - Grabellus, M. AU - Flannery, M. AU - Schondorf, T. PY - 2008 DA - 2008// TI - The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditions JO - Diabetes Technol Ther VL - 10 UR - https://doi.org/10.1089/dia.2008.0244 DO - 10.1089/dia.2008.0244 ID - Karagiannis2008 ER - TY - JOUR AU - McAlister, F. A. AU - Eurich, D. T. AU - Majumdar, S. R. AU - Johnson, J. A. PY - 2008 DA - 2008// TI - The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy JO - Eur J Heart Fail VL - 10 UR - https://doi.org/10.1016/j.ejheart.2008.05.013 DO - 10.1016/j.ejheart.2008.05.013 ID - McAlister2008 ER - TY - JOUR AU - Chokrungvaranon, N. AU - Chentanez, T. AU - Arakaki, R. F. PY - 2007 DA - 2007// TI - Clinical experience with exenatide in predominantly Asian and Pacific Islander patients with type 2 diabetes JO - Endocrine VL - 32 UR - https://doi.org/10.1007/s12020-008-9042-5 DO - 10.1007/s12020-008-9042-5 ID - Chokrungvaranon2007 ER - TY - JOUR AU - Asche, C. V. AU - McAdam-Marx, C. AU - Shane-McWhorter, L. AU - Sheng, X. AU - Plauschinat, C. A. PY - 2008 DA - 2008// TI - Evaluation of adverse events of oral antihyperglycaemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysis JO - Drugs Aging VL - 25 UR - https://doi.org/10.2165/00002512-200825070-00006 DO - 10.2165/00002512-200825070-00006 ID - Asche2008 ER - TY - JOUR AU - Hanefeld, M. AU - Pfutzner, A. AU - Forst, T. AU - Lubben, G. PY - 2006 DA - 2006// TI - Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care study JO - Curr Med Res Opin VL - 22 UR - https://doi.org/10.1185/030079906X112598 DO - 10.1185/030079906X112598 ID - Hanefeld2006 ER - TY - JOUR AU - Olansky, L. AU - Marchetti, A. AU - Lau, H. PY - 2003 DA - 2003// TI - Multicenter retrospective assessment of thiazolidinedione monotherapy and combination therapy in patients with type 2 diabetes: Comparative subgroup analyses of glycemic control and blood lipid levels JO - Clin Ther VL - 25 UR - https://doi.org/10.1016/S0149-2918(03)80243-6 DO - 10.1016/S0149-2918(03)80243-6 ID - Olansky2003 ER - TY - JOUR AU - Blonde, L. AU - Dailey, G. E. AU - Jabbour, S. A. AU - Reasner, C. A. AU - Mills, D. J. PY - 2004 DA - 2004// TI - Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study JO - Curr Med Res Opin VL - 20 UR - https://doi.org/10.1185/030079904125003278 DO - 10.1185/030079904125003278 ID - Blonde2004 ER - TY - JOUR AU - Hermann, L. S. AU - Nilsson, B. AU - Wettre, S. PY - 2004 DA - 2004// TI - Vitamin B12 status of patients treated with metformin: A cross-sectional cohort study JO - Br J Diabetes Vasc Dis VL - 4 UR - https://doi.org/10.1177/14746514040040060701 DO - 10.1177/14746514040040060701 ID - Hermann2004 ER - TY - JOUR AU - Feher, M. D. AU - Al-Mrayat, M. AU - Brake, J. AU - Leong, K. S. PY - 2007 DA - 2007// TI - Tolerability of prolonged-release metformin (Glucophage(registered trademark) SR) in individuals intolerant to standard metformin - Results from four UK centres JO - Br J Diabetes Vasc Dis VL - 7 UR - https://doi.org/10.1177/14746514070070050501 DO - 10.1177/14746514070070050501 ID - Feher2007 ER - TY - JOUR AU - Hussein, Z. AU - Wentworth, J. M. AU - Nankervis, A. J. AU - Proietto, J. AU - Colman, P. G. PY - 2004 DA - 2004// TI - Effectiveness and side effects of thiazolidinediones for type 2 diabetes: real-life experience from a tertiary hospital JO - Med J Aust VL - 181 ID - Hussein2004 ER - TY - JOUR AU - Hung, Y. J. AU - Kuo, S. W. AU - Wang, C. H. AU - Chang, H. Y. AU - Hsieh, S. H. AU - Landen, H. PY - 2006 DA - 2006// TI - Postmarketing surveillance of acarbose treatment in Taiwanese patients with type 2 diabetes mellitus JO - Clin Drug Invest VL - 26 UR - https://doi.org/10.2165/00044011-200626100-00002 DO - 10.2165/00044011-200626100-00002 ID - Hung2006 ER - TY - JOUR AU - Twaites, B. AU - Wilton, L. V. AU - Layton, D. AU - Shakir, S. A. W. PY - 2007 DA - 2007// TI - Safety of nateglinide as used in general practice in England: results of a prescription-event monitoring study JO - Acta Diabetol VL - 44 UR - https://doi.org/10.1007/s00592-007-0010-y DO - 10.1007/s00592-007-0010-y ID - Twaites2007 ER - TY - JOUR AU - Hershon, K. S. AU - Hershon, P. M. PY - 2000 DA - 2000// TI - Primary, secondary, tertiary, and quaternary treatment with troglitazone in type 2 diabetes mellitus in an outpatient clinical practice JO - Endocrine Practice VL - 6 UR - https://doi.org/10.4158/EP.6.1.20 DO - 10.4158/EP.6.1.20 ID - Hershon2000 ER - TY - JOUR AU - Furlong, N. J. AU - McNulty, S. J. AU - O'Brien, S. V. AU - Hardy, K. J. PY - 2002 DA - 2002// TI - Comparison of metformin versus sulphonylurea in combination with daily NPH insulin in patients with type 2 diabetes inadequately controlled on oral hypoglycaemic agents: Median follow-up 29 months JO - Pract Diabetes Int VL - 19 UR - https://doi.org/10.1002/pdi.399 DO - 10.1002/pdi.399 ID - Furlong2002 ER - TY - JOUR AU - Alvarez Guisasola, F. AU - Tofé Povedano, S. AU - Krishnarajah, G. AU - Lyu, R. AU - Mavros, P. AU - Yin, D. PY - 2008 DA - 2008// TI - Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study JO - Diabetes Obes Metab VL - 10 UR - https://doi.org/10.1111/j.1463-1326.2008.00882.x DO - 10.1111/j.1463-1326.2008.00882.x ID - Alvarez Guisasola2008 ER - TY - JOUR AU - Delea, T. E. AU - Edelsberg, J. S. AU - Hagiwara, M. AU - Oster, G. AU - Phillips, L. S. PY - 2003 DA - 2003// TI - Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.11.2983 DO - 10.2337/diacare.26.11.2983 ID - Delea2003 ER - TY - JOUR AU - Schatz, H. AU - Schoppel, K. AU - Lehwalder, D. AU - Schandry, R. PY - 2003 DA - 2003// TI - Efficacy, tolerability and safety of nateglinide in combination with metformin. Results from a study under general practice conditions JO - Exp Clin Endocrinol Diabetes VL - 111 UR - https://doi.org/10.1055/s-2003-41752 DO - 10.1055/s-2003-41752 ID - Schatz2003 ER - TY - JOUR AU - Marceille, J. R. AU - Goins, J. A. AU - Soni, R. AU - Biery, J. C. AU - Lee, T. A. PY - 2004 DA - 2004// TI - Chronic heart failure-related interventions after starting rosiglitazone in patients receiving insulin JO - Pharmacotherapy VL - 24 UR - https://doi.org/10.1592/phco.24.14.1317.43155 DO - 10.1592/phco.24.14.1317.43155 ID - Marceille2004 ER - TY - JOUR AU - King, A. B. AU - Armstrong, D. U. PY - 2002 DA - 2002// TI - Lipid response to pioglitazone in diabetic patients: Clinical observations from a retrospective chart review JO - Diabetes Technol Ther VL - 4 UR - https://doi.org/10.1089/15209150260007354 DO - 10.1089/15209150260007354 ID - King2002 ER - TY - JOUR AU - Maru, S. AU - Koch, G. G. AU - Stender, M. AU - Clark, D. AU - Gibowski, L. AU - Petri, H. AU - White, A. D. AU - Simpson, R. J. PY - 2005 DA - 2005// TI - Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting JO - Diabetes Care VL - 28 UR - https://doi.org/10.2337/diacare.28.1.20 DO - 10.2337/diacare.28.1.20 ID - Maru2005 ER - TY - JOUR AU - Nichols, G. A. AU - Koro, C. E. AU - Gullion, C. M. AU - Ephross, S. A. AU - Brown, J. B. PY - 2005 DA - 2005// TI - The incidence of congestive heart failure associated with antidiabetic therapies JO - Diabetes Metab Res Rev VL - 21 UR - https://doi.org/10.1002/dmrr.480 DO - 10.1002/dmrr.480 ID - Nichols2005 ER - TY - JOUR AU - Miller, C. D. AU - Phillips, L. S. AU - Ziemer, D. C. AU - Gallina, D. L. AU - Cook, C. B. AU - El-Kebbi, I. M. PY - 2001 DA - 2001// TI - Hypoglycemia in patients with type 2 diabetes mellitus JO - Arch Intern Med VL - 161 UR - https://doi.org/10.1001/archinte.161.13.1653 DO - 10.1001/archinte.161.13.1653 ID - Miller2001 ER - TY - JOUR AU - Shaya, F. T. AU - Shin, J. Y. AU - Mullins, C. D. AU - El Khoury, A. C. AU - Garber, H. PY - 2005 DA - 2005// TI - Risk of heart failure with the use of thiazolidinediones within a medicaid population JO - Pharmacy Therapeutics VL - 30 ID - Shaya2005 ER - TY - JOUR AU - Filioussi, K. AU - Bonovas, S. AU - Katsaros, T. PY - 2003 DA - 2003// TI - Should we screen diabetic patients using biguanides for megaloblastic anaemia? JO - Aust Fam Physician VL - 32 ID - Filioussi2003 ER - TY - JOUR AU - Grant, R. W. AU - Devita, N. G. AU - Singer, D. E. AU - Meigs, J. B. PY - 2003 DA - 2003// TI - Polypharmacy and medication adherence in patients with type 2 diabetes JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.5.1408 DO - 10.2337/diacare.26.5.1408 ID - Grant2003 ER - TY - JOUR AU - Chalasani, N. AU - Teal, E. AU - Hall, S. D. PY - 2005 DA - 2005// TI - Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes JO - Am J Gastroenterol VL - 100 UR - https://doi.org/10.1111/j.1572-0241.2005.41690.x DO - 10.1111/j.1572-0241.2005.41690.x ID - Chalasani2005 ER - TY - JOUR AU - Jha, A. K. AU - Kuperman, G. J. AU - Teich, J. M. AU - Leape, L. AU - Shea, B. AU - Rittenberg, E. AU - Burdick, E. AU - Seger, D. L. AU - Vander Vliet, M. AU - Bates, D. W. PY - 1998 DA - 1998// TI - Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report JO - J Am Med Inform Assoc VL - 5 UR - https://doi.org/10.1136/jamia.1998.0050305 DO - 10.1136/jamia.1998.0050305 ID - Jha1998 ER - TY - JOUR AU - Nebeker, J. R. AU - Barach, P. AU - Samore, M. H. PY - 2004 DA - 2004// TI - Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting JO - Ann Intern Med VL - 140 UR - https://doi.org/10.7326/0003-4819-140-10-200405180-00017 DO - 10.7326/0003-4819-140-10-200405180-00017 ID - Nebeker2004 ER - TY - JOUR AU - Pakhomov, S. V. AU - Jacobsen, S. J. AU - Chute, C. G. AU - Roger, V. L. PY - 2008 DA - 2008// TI - Agreement between patient-reported symptoms and their documentation in the medical record JO - Am J Manag Care VL - 14 ID - Pakhomov2008 ER - TY - JOUR AU - Honigman, B. AU - Light, P. AU - Pulling, R. M. AU - Bates, D. W. PY - 2001 DA - 2001// TI - A computerized method for identifying incidents associated with adverse drug events in outpatients JO - Int J Med Inform VL - 61 UR - https://doi.org/10.1016/S1386-5056(00)00131-3 DO - 10.1016/S1386-5056(00)00131-3 ID - Honigman2001 ER - TY - JOUR AU - Golomb, B. A. AU - McGraw, J. J. AU - Evans, M. A. AU - Dimsdale, J. E. PY - 2007 DA - 2007// TI - Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance JO - Drug Saf VL - 30 UR - https://doi.org/10.2165/00002018-200730080-00003 DO - 10.2165/00002018-200730080-00003 ID - Golomb2007 ER - TY - JOUR AU - Fromme, E. K. AU - Eilers, K. M. AU - Mori, M. AU - Hsieh, Y. C. AU - Beer, T. M. PY - 2004 DA - 2004// TI - How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30 JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.03.025 DO - 10.1200/JCO.2004.03.025 ID - Fromme2004 ER - TY - JOUR AU - Van Grootheest, K. AU - van Puijenbroek, E. P. AU - de Jong-van den Berg, L. T. PY - 2004 DA - 2004// TI - Do pharmacists' reports of adverse drug reactions reflect patients' concerns? JO - Pharm World Sci VL - 26 UR - https://doi.org/10.1023/B:PHAR.0000026802.81401.bb DO - 10.1023/B:PHAR.0000026802.81401.bb ID - Van Grootheest2004 ER - TY - JOUR AU - Van Grootheest, K. AU - de Jong-van den Berg, L. T. PY - 2004 DA - 2004// TI - Patients' role in reporting adverse drug reactions JO - Expert Opin Drug Saf VL - 3 UR - https://doi.org/10.1517/14740338.3.4.363 DO - 10.1517/14740338.3.4.363 ID - Van Grootheest2004 ER - TY - JOUR AU - Jarernsiripornkul, N. AU - Kakaew, W. AU - Loalukkana, W. AU - Krska, J. PY - 2009 DA - 2009// TI - Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs JO - Pharmacoepidemiol Drug Saf VL - 18 UR - https://doi.org/10.1002/pds.1708 DO - 10.1002/pds.1708 ID - Jarernsiripornkul2009 ER - TY - JOUR AU - Mitchell, A. S. AU - Henry, D. A. AU - Sanson-Fisher, R. AU - O'Connell, D. L. PY - 1988 DA - 1988// TI - Patients as a direct source of information on adverse drug reactions JO - BMJ VL - 297 UR - https://doi.org/10.1136/bmj.297.6653.891 DO - 10.1136/bmj.297.6653.891 ID - Mitchell1988 ER - TY - JOUR AU - Ferrari, A. AU - Spaccapelo, L. AU - Gallesi, D. AU - Sternieri, E. PY - 2009 DA - 2009// TI - Focus on headache as an adverse reaction to drugs JO - J Headache Pain VL - 10 UR - https://doi.org/10.1007/s10194-009-0127-1 DO - 10.1007/s10194-009-0127-1 ID - Ferrari2009 ER - TY - JOUR AU - Aagaard, L. AU - Nielsen, L. H. AU - Hansen, E. H. PY - 2009 DA - 2009// TI - Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006 JO - Drug Saf VL - 32 UR - https://doi.org/10.2165/11316680-000000000-00000 DO - 10.2165/11316680-000000000-00000 ID - Aagaard2009 ER - TY - JOUR AU - Jarernsiripornkul, N. AU - Krska, J. AU - Capps, P. A. AU - Richards, R. M. AU - Lee, A. PY - 2002 DA - 2002// TI - Patient reporting of potential adverse drug reactions: a methodological study JO - Br J Clin Pharmacol VL - 53 UR - https://doi.org/10.1046/j.0306-5251.2001.01547.x DO - 10.1046/j.0306-5251.2001.01547.x ID - Jarernsiripornkul2002 ER - TY - JOUR AU - Foster, J. M. AU - van der Molen, T. AU - Caeser, M. AU - Hannaford, P. PY - 2008 DA - 2008// TI - The use of questionnaires for measuring patient-reported side effects of drugs: its importance and methodological challenges JO - Pharmacoepidemiol Drug Saf VL - 17 UR - https://doi.org/10.1002/pds.1533 DO - 10.1002/pds.1533 ID - Foster2008 ER - TY - JOUR AU - Ten Berg, M. J. AU - Huisman, A. AU - van den Bemt, P. M. AU - Schobben, A. F. AU - Egberts, A. C. AU - van Solinge, W. W. PY - 2007 DA - 2007// TI - Linking laboratory and medication data: new opportunities for pharmacoepidemiological research JO - Clin Chem Lab Med VL - 45 UR - https://doi.org/10.1515/CCLM.2007.009 DO - 10.1515/CCLM.2007.009 ID - Ten Berg2007 ER - TY - JOUR AU - Honigman, B. AU - Lee, J. AU - Rothschild, J. AU - Light, P. AU - Pulling, R. M. AU - Yu, T. AU - Bates, D. W. PY - 2001 DA - 2001// TI - Using computerized data to identify adverse drug events in outpatients JO - J Am Med Inform Assoc VL - 8 UR - https://doi.org/10.1136/jamia.2001.0080254 DO - 10.1136/jamia.2001.0080254 ID - Honigman2001 ER - TY - JOUR AU - Eichler, H. G. AU - Pignatti, F. AU - Flamion, B. AU - Leufkens, H. AU - Breckenridge, A. PY - 2008 DA - 2008// TI - Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma JO - Nat Rev Drug Discov VL - 7 UR - https://doi.org/10.1038/nrd2664 DO - 10.1038/nrd2664 ID - Eichler2008 ER - TY - JOUR AU - Egberts, T. C. AU - Smulders, M. AU - de Koning, F. H. AU - Meyboom, R. H. AU - Leufkens, H. G. PY - 1996 DA - 1996// TI - Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals JO - BMJ VL - 313 UR - https://doi.org/10.1136/bmj.313.7056.530 DO - 10.1136/bmj.313.7056.530 ID - Egberts1996 ER - TY - JOUR AU - Golder, S. AU - McIntosh, H. M. AU - Duffy, S. AU - Glanville, J. PY - 2006 DA - 2006// TI - Developing efficient search strategies to identify reports of adverse effects in MEDLINE and EMBASE JO - Health Info Libr J VL - 23 UR - https://doi.org/10.1111/j.1471-1842.2006.00634.x DO - 10.1111/j.1471-1842.2006.00634.x ID - Golder2006 ER - TY - JOUR AU - McIntosh, H. M. AU - Woolacott, N. F. AU - Bagnall, A. M. PY - 2004 DA - 2004// TI - Assessing harmful effects in systematic reviews JO - BMC Med Res Methodol VL - 4 UR - https://doi.org/10.1186/1471-2288-4-19 DO - 10.1186/1471-2288-4-19 ID - McIntosh2004 ER - TY - JOUR AU - Donekal, S. AU - Shomali, M. E. PY - 2008 DA - 2008// TI - Effectiveness of the novel anti-diabetes medication exenatide in everyday practice: Comparison with clinical trials JO - Diabetes Res Clin Pract VL - 80 UR - https://doi.org/10.1016/j.diabres.2008.01.014 DO - 10.1016/j.diabres.2008.01.014 ID - Donekal2008 ER - TY - JOUR AU - Redondo-Capafons, S. AU - Garriga Biosca, M. R. AU - Pla Poblador, R. PY - 2005 DA - 2005// TI - Follow-up of the use of metformin among the high risk population JO - Farm Hosp VL - 29 UR - https://doi.org/10.1016/S1130-6343(05)73697-7 DO - 10.1016/S1130-6343(05)73697-7 ID - Redondo-Capafons2005 ER - TY - JOUR AU - Burk, M. AU - Morreale, A. P. AU - Cunningham, F. PY - 2004 DA - 2004// TI - Conversion from troglitazone to rosiglitazone or pioglitazone in the VA: A multicenter DUE JO - Formulary VL - 39 ID - Burk2004 ER - TY - JOUR AU - Manley, H. J. AU - Allcock, N. M. PY - 2003 DA - 2003// TI - Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis JO - Pharmacotherapy VL - 23 UR - https://doi.org/10.1592/phco.23.7.861.32727 DO - 10.1592/phco.23.7.861.32727 ID - Manley2003 ER - TY - JOUR AU - Swislocki, A. L. AU - Khuu, Q. AU - Liao, E. AU - Wu, E. AU - Beza, F. AU - Lopez, J. AU - Kwan, G. AU - Noth, R. H. PY - 1999 DA - 1999// TI - Safety and efficacy of metformin in a restricted formulary JO - Am J Manag Care VL - 5 ID - Swislocki1999 ER - TY - JOUR AU - Tang, W. H. AU - Francis, G. S. AU - Hoogwerf, B. J. AU - Young, J. B. PY - 2003 DA - 2003// TI - Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure JO - Am Coll Cardiol VL - 41 UR - https://doi.org/10.1016/S0735-1097(03)00159-1 DO - 10.1016/S0735-1097(03)00159-1 ID - Tang2003 ER - TY - JOUR AU - Fehmann, H. C. PY - 2001 DA - 2001// TI - The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office JO - MMW Fortschr Med VL - 119 ID - Fehmann2001 ER - TY - JOUR AU - Kane, M. P. AU - Busch, R. S. AU - Bakst, G. AU - Hamilton, R. A. PY - 2004 DA - 2004// TI - Substitution of pioglitazone for troglitazone in patients with type 2 diabetes JO - Endocr Pract VL - 10 UR - https://doi.org/10.4158/EP.10.1.18 DO - 10.4158/EP.10.1.18 ID - Kane2004 ER - TY - JOUR AU - Kawamori, R. AU - Kadowaki, T. AU - Onji, M. AU - Seino, Y. AU - Akanuma, Y. PY - 2007 DA - 2007// TI - Hepatic safety profile and glycemic control of pioglitazone in more than 20,000 patients with type 2 diabetes mellitus: postmarketing surveillance study in Japan JO - Diabetes Res Clin Pract VL - 76 UR - https://doi.org/10.1016/j.diabres.2006.08.017 DO - 10.1016/j.diabres.2006.08.017 ID - Kawamori2007 ER - TY - JOUR AU - Mertes, G. PY - 2001 DA - 2001// TI - Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study JO - Diabetes Res Clin Pract VL - 52 UR - https://doi.org/10.1016/S0168-8227(01)00221-2 DO - 10.1016/S0168-8227(01)00221-2 ID - Mertes2001 ER - TY - JOUR AU - Pan, C. Y. AU - Landen, H. PY - 2007 DA - 2007// TI - Post-marketing surveillance of acarbose treatment in patients with type 2 diabetes mellitus and subjects with impaired glucose tolerance in China JO - Clin Drug Invest VL - 27 UR - https://doi.org/10.2165/00044011-200727060-00003 DO - 10.2165/00044011-200727060-00003 ID - Pan2007 ER - TY - JOUR AU - Rosak, C. AU - Petzoldt, R. AU - Wolf, R. AU - Reblin, T. AU - Dehmel, B. AU - Seidel, D. PY - 2005 DA - 2005// TI - Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes JO - Int J Clin Pract VL - 59 UR - https://doi.org/10.1111/j.1368-5031.2005.00652.x DO - 10.1111/j.1368-5031.2005.00652.x ID - Rosak2005 ER - TY - JOUR AU - Scholz, G. H. AU - Schneider, K. AU - Knirsch, W. AU - Becker, G. PY - 2001 DA - 2001// TI - Efficacy and tolerability of glimepiride in daily practice: A non-interventional observational cohort study JO - Clin Drug Invest VL - 21 UR - https://doi.org/10.2165/00044011-200121090-00001 DO - 10.2165/00044011-200121090-00001 ID - Scholz2001 ER - TY - JOUR AU - Slama, G. AU - Eschwège, E. AU - Bernard, M. H. AU - Grimaldi, A. AU - Oppert, J. M. AU - Pouchain, D. AU - Bégaud, B. PY - 2008 DA - 2008// TI - One-year follow-up in real clinical practice conditions of type 2 diabetic patients treated with rosiglitazone: the Avantage study JO - Ann Endocrinol VL - 69 UR - https://doi.org/10.1016/j.ando.2007.10.024 DO - 10.1016/j.ando.2007.10.024 ID - Slama2008 ER - TY - JOUR AU - Spengler, M. AU - Schmitz, H. AU - Landen, H. PY - 2005 DA - 2005// TI - Evaluation of the efficacy and tolerability of acarbose in patients with diabetes mellitus a postmarketing surveillance study JO - Clin Drug Invest VL - 25 UR - https://doi.org/10.2165/00044011-200525100-00004 DO - 10.2165/00044011-200525100-00004 ID - Spengler2005 ER - TY - JOUR AU - Kasliwal, R. AU - Wilton, L. V. AU - Shakir, S. A. W. PY - 2008 DA - 2008// TI - Monitoring the safety of pioglitazone: Results of a prescription-event monitoring study of 12 772 patients in England JO - Drug Saf VL - 31 UR - https://doi.org/10.2165/00002018-200831100-00003 DO - 10.2165/00002018-200831100-00003 ID - Kasliwal2008 ER - TY - JOUR AU - Kubota, K. AU - Kawabe, E. AU - Hinotsu, S. AU - Hamada, C. AU - Ohashi, Y. AU - Kurokawa, K. PY - 2000 DA - 2000// TI - Pilot study of prescription-event monitoring in Japan comparing troglitazone with alternative oral hypoglycemics JO - Eur J Clin Pharmacol VL - 56 UR - https://doi.org/10.1007/s002280000232 DO - 10.1007/s002280000232 ID - Kubota2000 ER - TY - JOUR AU - Marshall, V. AU - Wilton, L. AU - Shakir, S. A. W. PY - 2006 DA - 2006// TI - Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study JO - Acta Diabetol VL - 43 UR - https://doi.org/10.1007/s00592-006-0203-9 DO - 10.1007/s00592-006-0203-9 ID - Marshall2006 ER - TY - JOUR AU - Casscells, S. W. AU - Granger, E. AU - Swedorske, J. AU - Goldhammer, R. AU - Shaheen, M. AU - Dorris, J. AU - Hong, A. AU - Wiktor, M. PY - 2008 DA - 2008// TI - A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among Military Health System beneficiaries, fiscal year 2003-2006 JO - Am J Ther VL - 15 UR - https://doi.org/10.1097/MJT.0b013e31817534d5 DO - 10.1097/MJT.0b013e31817534d5 ID - Casscells2008 ER - TY - JOUR AU - Rajagopalan, R. AU - Iyer, S. AU - Perez, A. PY - 2005 DA - 2005// TI - Comparison of pioglitazone with other antidiabetic drugs for associated incidence of liver failure: no evidence of increased risk of liver failure with pioglitazone JO - Diabetes Obes Metab VL - 7 UR - https://doi.org/10.1111/j.1463-1326.2004.00382.x DO - 10.1111/j.1463-1326.2004.00382.x ID - Rajagopalan2005 ER - TY - JOUR AU - Monster, T. B. AU - de Jong, P. E. AU - de Jong-van den Berg, L. T. PY - 2003 DA - 2003// TI - Drug-induced renal function impairment: a population-based survey JO - Pharmacoepidemiol Drug Saf VL - 12 UR - https://doi.org/10.1002/pds.811 DO - 10.1002/pds.811 ID - Monster2003 ER - TY - JOUR AU - Abbasi, A. A. AU - Kasmikha, R. AU - Sotingeanu, D. G. PY - 2000 DA - 2000// TI - Metformin-induced lacticacidemia in patients with type 2 diabetes mellitus JO - Endocr Pract VL - 6 UR - https://doi.org/10.4158/EP.6.6.442 DO - 10.4158/EP.6.6.442 ID - Abbasi2000 ER - TY - JOUR AU - Gavin, L. A. AU - Barth, J. AU - Arnold, D. AU - Shaw, R. PY - 2000 DA - 2000// TI - Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control JO - Endocr Pract VL - 6 UR - https://doi.org/10.4158/EP.6.4.305 DO - 10.4158/EP.6.4.305 ID - Gavin2000 ER - TY - JOUR AU - Taki, H. AU - Maki, T. AU - Iso, T. AU - Iwamoto, K. AU - Kajiura, T. PY - 2006 DA - 2006// TI - Study of nateglinide in Japan: long-term treatment of patients with type 2 diabetes JO - Adv Ther VL - 23 UR - https://doi.org/10.1007/BF02850136 DO - 10.1007/BF02850136 ID - Taki2006 ER -